منابع مشابه
Very low HbA1C, is it a problem?
Dear Editor An important problem to manage diabetes mellitus is controlling the patients` blood glucose. Fluctuation of blood glucose results in molecular biochemistry change and can result in unwanted diabetic complications (1). In clinical practice, hemoglobin A1C (HbA1C) is a common useful laboratory test to follow-up patients with diabetes (2). Sometimes, an unexpecte...
متن کاملPenicillin: The Old/New Wonder Drug
Although it was discovered in 1928 by Alexander Fleming, a microbiologist at St. Mary’s Hospital in London, penicillin languished for more than a decade before its importance was noticed. As its antimicrobial properties became more apparent, large enough quantities were produced for clinical trials through the efforts of Florey et al. [1]. Then came World War II, and the U.S. government became ...
متن کاملNeuraxial Dexmedetomidine: Wonder Drug or Simply Harmful
Copyright © 2015, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. In ...
متن کاملInsulin: a wonder drug in the critically ill?
Stress hyperglycaemia is a common event in acute critical illness. There is increasing evidence that maintaining normoglycaemia and treatment with insulin (or with glucose-insulin-potassium [GIK]), even in non-diabetic persons, is helpful in limiting organ damage after myocardial infarction, stroke, traumatic brain injury and other conditions, even though the conditions may be accompanied by in...
متن کاملImatinib for Pulmonary Arterial Hypertension - Wonder Drug or Killer Drug?
tinib showed significant improvement in hemodynamics and physical capacity after 24 months of therapy [7] . Based on these data and independent of any interests on the part of the pharmaceutical industry, pulmonary hypertension specialists in several countries have offered open-label imatinib to their PAH patients as a palliative treatment, but, unfortunately, with little in the way of publishe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical Journal Armed Forces India
سال: 2001
ISSN: 0377-1237
DOI: 10.1016/s0377-1237(01)80090-3